GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Sino-Agri Leading Biosciences Co Ltd (SHSE:603970) » Definitions » Capex-to-Revenue

Sino-Agri Leading Biosciences Co (SHSE:603970) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sino-Agri Leading Biosciences Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sino-Agri Leading Biosciences Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-0.82 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥2,397.49 Mil.

Hence, Sino-Agri Leading Biosciences Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


Sino-Agri Leading Biosciences Co Capex-to-Revenue Historical Data

The historical data trend for Sino-Agri Leading Biosciences Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino-Agri Leading Biosciences Co Capex-to-Revenue Chart

Sino-Agri Leading Biosciences Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sino-Agri Leading Biosciences Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sino-Agri Leading Biosciences Co's Capex-to-Revenue

For the Agricultural Inputs subindustry, Sino-Agri Leading Biosciences Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino-Agri Leading Biosciences Co's Capex-to-Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Sino-Agri Leading Biosciences Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sino-Agri Leading Biosciences Co's Capex-to-Revenue falls into.



Sino-Agri Leading Biosciences Co Capex-to-Revenue Calculation

Sino-Agri Leading Biosciences Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.368) / 10459.621
=0.00

Sino-Agri Leading Biosciences Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.817) / 2397.491
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino-Agri Leading Biosciences Co  (SHSE:603970) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Sino-Agri Leading Biosciences Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sino-Agri Leading Biosciences Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino-Agri Leading Biosciences Co (SHSE:603970) Business Description

Traded in Other Exchanges
N/A
Address
No. A1, Xuanwumenwai Street, 9th Floor, Block C, Global Finance & News Center, Xicheng District, Beijing, CHN, 100052
Sino-Agri Leading Biosciences Co Ltd s a China-based company engaged in the production and distribution of agricultural products. The company manufactures and sells agricultural means of production, such as chemical fertilizer, pesticides, agricultural film, seeds, and agricultural machinery and other related products.

Sino-Agri Leading Biosciences Co (SHSE:603970) Headlines

No Headlines